Biosig Instruments, Inc. v. Nautilus, Inc., No. 12-1289 (Fed. Cir. 2015)
Annotate this CaseBiosig’s 753 patent is directed to a heart rate monitor that purports to improve upon the prior art by effectively eliminating “noise” signals during the process of detecting a user’s heart rate. The patent discloses an apparatus preferably mounted on exercise equipment that measures heart rates by processing electrocardiograph signals from which electromyogram signals are substantially removed. Biosig sued, alleging that Nautilus infringed claims 1 and 11 of the 753 patent. After claim construction, the district court granted Nautilus’s motion for summary judgment, finding the patent invalid for indefiniteness. The Federal Circuit found the claims at issue were not invalid for indefiniteness. The Supreme Court, rejected the “not amenable to construction or insolubly ambiguous” standard and vacated and remanded. The Federal Circuit maintained its reversal of the district court’s determination that Biosig’s patent claims are indefinite, holding that the “spaced relationship” phrase “inform[s] those skilled in the art about the scope of the invention with reasonable certainty.”
This opinion or order relates to an opinion or order originally issued on April 26, 2013.
Some case metadata and case summaries were written with the help of AI, which can produce inaccuracies. You should read the full case before relying on it for legal research purposes.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.